XML 29 R7.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Statements Of Cash Flows (USD $)
In Thousands
9 Months Ended119 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Cash flows used in operating activities:   
Net loss$ (3,734)$ (6,825)$ (62,044)
Adjustments to reconcile net loss to net cash used in operating activities:   
Gain on bargain purchase  (25,282)
Gain on patent rights assignment(2,000) (2,000)
Depreciation and amortization5182551,653
Non-cash interest expense  211
Share-based compensation2323372,206
Issuance of warrants for lease termination  377
Accretion of liabilities  152
Impairment of property and equipment  125
Impairment of in-process research and development  6,000
Write-off of deferred tax liability  (2,281)
Gain on marketable securities available for sale  (263)
(Gain) loss from disposal of property and equipment4(4)71
Other, net  267
Change in operating assets and liabilities (net of amounts acquired):   
Other current assets(56)102,472
Other assets60 7,226
Accounts payable(104)(264)(1,906)
Accrued expenses and other liabilities(384)(606)(19,148)
Deferred rent(259)(85)57
Net cash used in operating activities(5,723)(7,182)(92,107)
Cash flows (used in) provided by investing activities:   
Cash received from Merger  30,392
Payment of deferred transaction costs  (1,186)
Purchase of property and equipment(1)(2)(1,861)
Proceeds from sale of marketable securities  15,369
Proceeds from sale of property and equipment26335
Proceeds from assignment of patent rights2,000 2,000
Net cash (used in) provided by investing activities2,001445,049
Cash flows (used in) provided by financing activities:   
Proceeds from issuance of convertible notes payable and related warrants for common stock  10,841
Proceeds from issuance of bank note payable  4,000
Proceeds from stock subject to repurchase  38
Proceeds from the issuance of preferred stock  32,316
Proceeds from the issuance of common stock3,0017,65910,856
Repayment of principal on bank note payable  (4,000)
Repayment of principal on convertible notes payables  (105)
Repayment of principal on vendor finance agreement(97) (97)
Net cash (used in) provided by financing activities2,4457,32152,806
Net (decrease) increase in cash and cash equivalents(1,277)1435,748
Cash and cash equivalents, beginning of period7,0257,763 
Cash and cash equivalents, end of period5,7487,9065,748
Supplemental cash flow information:   
Interest paid4 111
Supplemental disclosure of noncash investing and financing transactions:   
Accrued interest on notes payable converted to equity  163
Warrant issued in connection with credit facility  111
Accrued deferred transaction costs  482
Vendor finance agreement50 50
Common Stock [Member]
   
Cash flows (used in) provided by financing activities:   
Payment of offering costs(459)(338)(797)
Preferred Stock [Member]
   
Cash flows (used in) provided by financing activities:   
Payment of offering costs  $ (246)